top of page

Ross Procedure


for Aortic Valve Replacement

The Ross procedure is a surgical procedure used to treat certain heart conditions, particularly aortic valve disease, in younger and middle-aged adults. It involves replacing a patient's diseased aortic valve with their own pulmonary valve, and then replacing the pulmonary valve with a pulmonary homograft (a donated human pulmonary valve) or an artificial valve.

The Ross procedure and bioprosthetic aortic valve replacement are two different approaches to treating aortic valve disease, and each has its own advantages and considerations. Here are some reasons why the Ross procedure may be considered preferable in certain cases:

  1. Durability: One of the primary advantages of the Ross procedure is that the patient's own pulmonary valve is used to replace the aortic valve. The patient's pulmonary valve is typically more durable and better suited to withstand the higher pressures of the aortic position compared to bioprosthetic valves. Bioprosthetic valves, which are made from animal or human tissue, have a limited lifespan and may require replacement after 10 to 15 years, especially in younger patients.

  2. Avoidance of long-term anticoagulation: With the Ross procedure, since the patient's own tissue is used, there is a reduced need for long-term anticoagulation therapy, which is typically required with mechanical valves. Bioprosthetic valves also do not require anticoagulation, making them an alternative to mechanical valves, but they still have a limited lifespan.

  3. Potential for growth and remodeling: The Ross procedure is particularly beneficial for younger patients because it allows for growth and remodeling of the pulmonary valve in the aortic position. This is especially advantageous for pediatric patients who would require multiple valve replacements as they grow. By using the patient's own pulmonary valve, the Ross procedure offers the potential for a more natural and adaptive valve replacement option.

  4. Reduced risk of valve degeneration: Bioprosthetic valves have the risk of degeneration over time, leading to narrowing or leakage. The Ross procedure reduces this risk as the patient's own pulmonary valve is less likely to degenerate.

  5. Potential for improved quality of life: The Ross procedure has shown favorable outcomes in terms of long-term survival, freedom from reoperation, and improved quality of life in select patient populations, particularly younger and active individuals. 


However, it's important to note that the Ross procedure is a more complex surgery than bioprosthetic valve replacement and carries its own set of risks and considerations. The decision between these procedures depends on various factors such as the patient's age, overall health, lifestyle, and the surgeon's expertise. Patients should consult with their healthcare provider or a cardiac surgeon to discuss the available options and determine the most suitable treatment approach for their individual case.

bottom of page